Crowdfunding platform

Capital Cell

Not rated yet, be the first to rate!

The biotechnology revolution is underway. In the last fifteen years, the emergence of new technologies and new socioeconomic paradigms has radically changed the way we innovate and invest in the future of our health.

As a result, biotechnology has become one of the largest and most profitable investment sectors in the world. A quarter of the world's venture capital investment goes to this sector, with returns that have been exceeding 20% per year for many years.

Capital Cell opens up an access route for private investors to an asset that, until now, was reserved for a few specialists or people with large fortunes.

This platform was created to make the work of a highly specialized team of professional investors, lawyers, financiers, scientists and health experts from around the world available to everyone.

It has never been so easy to invest in the most profitable sector with the greatest social impact.

Basic information
112 projects funded
99000000.0 EUR funded amount

Licence/regulation: CAPITAL CELL licensed under European Crowdfunding Service Providers (ECSP) regulation

For Investors
Limitations: In principle, any citizen or company of any country that is not on the list of tax havens of the Spanish government. However, in case of natural person it is required to have the NIE and in case of company, Spanish CIF.
Minium investement: 100 EUR
Useful Information
How does Capital Cell work?

Capital Cell operates as an Equity crowdfunding platform offering investors to invest in startups and early-stage companies through acquiring company shares. On the other hand offering companies am alternative fundraising tool to raise funds from a large pool of investors.

What investments does Capital Cell offer?

On Capital Cell  you can invest in  European startups from healthcare and biotech industries 

What is a risk when investing on Capital Cell ?

When investing on Capital Cell you invest in early-stage companies which makes it a high-risk investment since statistically 9 of 10 early-stage companies fail. You as an investor have to carefully evaluate such investments including product, product-market fit, company team and their ability to successfully develop a company, total addressable and reachable market and company growth potential, and other risks depending on business specifics.
 

Rating

This platform have no rating yet. Be the first to rate!

Capital Cell Reviews

Filter By Rating
  • Sort By
  • Best alternative to Capital Cell

    logo
    200crowd
    Not rated yet, Be the first to rate!
    flag Italy
    Equity crowdfunding icon Equity crowdfunding
    EUR
    20.0M EUR 500 min. Invest.
    Italian
    logo
    BacktoWork
    Not rated yet, Be the first to rate!
    flag Italy
    Equity crowdfunding icon Equity crowdfunding
    EUR
    500 min. Invest.
    Italian
    logo
    Capital Cell
    Not rated yet, Be the first to rate!
    flag Spain
    Equity crowdfunding icon Equity crowdfunding Healthcare icon Healthcare
    EUR
    99.0M EUR 100 min. Invest.
    Swedish French Dutch Spanish English
    logo
    Companisto
    Not rated yet, Be the first to rate!
    flag Germany
    Equity crowdfunding icon Equity crowdfunding
    EUR
    228.78M EUR 250 min. Invest.
    German
    logo
    Seedrs
    Not rated yet, Be the first to rate!
    flag United Kingdom
    Equity crowdfunding icon Equity crowdfunding
    GBP
    3053.33M EUR 10 min. Invest.
    English
    logo
    Crowdcube
    Not rated yet, Be the first to rate!
    flag United Kingdom
    Equity crowdfunding icon Equity crowdfunding
    GBP
    1357.04M EUR 10 min. Invest.
    English French Spanish